Mannitol Versus Supportive Care in Ciguatera Fish Poisoning
Study Details
Study Description
Brief Summary
Ciguatera poisoning, caused by the ingestion of ciguatoxin-containing fish, is a global public health concern. In the US, the vast majority of ciguatera poisonings occur in Florida, followed by Hawaii and California. Equipoise exists in the medical literature regarding the effectiveness of mannitol therapy in treatment of ciguatera poisoning. While there are many case reports attesting to its utility, the only randomized control trial (RCT) comparing mannitol therapy with supportive care failed to show any significant benefit from mannitol treatment for a variety of clinical outcomes. Investigators therefore propose a second, larger RCT to test this question.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Phase 3 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
No Intervention: Control Patients will receive supportive care measures. |
|
Experimental: Investigational Patients will receive 500mL of 20% mannitol |
Drug: Mannitol
|
Outcome Measures
Primary Outcome Measures
- Symptom score [24 hours]
Covers a variety of neurological and gastrointestinal symptoms on a 0-4 score
Eligibility Criteria
Criteria
Inclusion Criteria:
- History consistent with ciguatera poisoning
Exclusion Criteria:
-
Minors
-
pregnant patients
-
those unable to give consent
-
severe congestive heart failure or renal failure
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University of South Florida
- Florida Poison Control Center
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CITX-2015